Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-12-28

Clinical Trial Update: "Lidocaine 4% Cream (LMX4) vs Placebo for Pain Due to Lumbar Puncture in Infants 0-60 Days of Age." [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating lidocaine 4% cream (LMX4) versus placebo for pain related to lumbar puncture in infants age 0-60 days; study completed with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • lidocaine 4% cream (LMX4) (lidocaine)

Snippet

Sponsor: State University of New York at Buffalo | Conditions: Pain | Phase 4 | Status: COMPLETED | Results posted: 2022-12-28